ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,714.60
-0.13%
S&P ASX All Technology
3,077.90
-0.48%
Brent Oil
82.075
-0.06%
US Dollar vs AUD
1.51449
0.05%
Bitcoin
66,346.40
-0.44%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) News

AZN

Astrazeneca (AZN)

Astrazeneca Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AZN
DateTimeSourceHeadlineSymbolCompany
13/06/202405:56Alliance NewsAlliance NewsAstraZeneca's Farxiga approved to treat paediatric type-2 diabetesLSE:AZNAstrazeneca Plc
13/06/202405:56Alliance NewsAlliance NewsAstraZeneca's Farxiga approved to treat paediatric type-2 diabetesLSE:AZNAstrazeneca Plc
13/06/202400:00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
10/06/202417:30Alliance NewsAlliance NewsTOP NEWS: Astra's Tagrisso gets US priority review for lung cancerLSE:AZNAstrazeneca Plc
10/06/202417:30Alliance NewsAlliance NewsTOP NEWS: Astra's Tagrisso gets US priority review for lung cancerLSE:AZNAstrazeneca Plc
05/06/202418:27Alliance NewsAlliance NewsAstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchaseLSE:AZNAstrazeneca Plc
05/06/202418:27Alliance NewsAlliance NewsAstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchaseLSE:AZNAstrazeneca Plc
05/06/202416:00RNS Regulatory NewsAstraZeneca PLC Acquisition of Fusion completedLSE:AZNAstrazeneca Plc
04/06/202421:00PR Newswire (US)AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024LSE:AZNAstrazeneca Plc
04/06/202400:05RNS Regulatory NewsAstraZeneca PLC Block listing Interim ReviewLSE:AZNAstrazeneca Plc
04/06/202400:00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
03/06/202417:59Alliance NewsAlliance NewsAstraZeneca cancer treatment Tagrisso recommended for approval in EULSE:AZNAstrazeneca Plc
03/06/202417:59Alliance NewsAlliance NewsAstraZeneca cancer treatment Tagrisso recommended for approval in EULSE:AZNAstrazeneca Plc
03/06/202416:00RNS Regulatory NewsAstraZeneca PLC Tagrisso plus chemo recommended for approval in EULSE:AZNAstrazeneca Plc
29/05/202417:54Alliance NewsAlliance NewsIN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trialLSE:AZNAstrazeneca Plc
29/05/202417:54Alliance NewsAlliance NewsIN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trialLSE:AZNAstrazeneca Plc
28/05/202416:00RNS Regulatory NewsAstraZeneca PLC Dato-DXd improved OS in nonsquamous lung cancerLSE:AZNAstrazeneca Plc
27/05/202416:49Alliance NewsAlliance NewsIN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXdLSE:AZNAstrazeneca Plc
27/05/202416:49Alliance NewsAlliance NewsIN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXdLSE:AZNAstrazeneca Plc
21/05/202421:18Alliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
21/05/202421:18Alliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
21/05/202417:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aimLSE:AZNAstrazeneca Plc
21/05/202417:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aimLSE:AZNAstrazeneca Plc
21/05/202416:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to deliver $80bn revenue by 2030LSE:AZNAstrazeneca Plc
20/05/202417:24Alliance NewsAlliance NewsTOP NEWS: AstraZeneca plans to build manufacturing plant in SingaporeLSE:AZNAstrazeneca Plc
20/05/202417:24Alliance NewsAlliance NewsTOP NEWS: AstraZeneca plans to build manufacturing plant in SingaporeLSE:AZNAstrazeneca Plc
20/05/202416:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to manufacture ADCs in SingaporeLSE:AZNAstrazeneca Plc
16/05/202419:27Alliance NewsAlliance NewsAstraZeneca trials yield positive results for immunocompromised patientsLSE:AZNAstrazeneca Plc
16/05/202419:27Alliance NewsAlliance NewsAstraZeneca trials yield positive results for immunocompromised patientsLSE:AZNAstrazeneca Plc
16/05/202416:00RNS Regulatory NewsAstraZeneca PLC SUPERNOVA Trial Met COVID-19 prevention endpointLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Your Recent History

NASDAQ
TSLA
Tesla
ASX
TLS
Telstra
ASX
FMG
Fortescue
NYSE
NKE
Nike
NASDAQ
AMZN
Amazon.com
ASX
WDC
Westfield
FTSE
UKX
FTSE 100
ASX
WES
Wesfarmers
ASX
QBE
QBE Insurance
ASX
MQG
Macquarie
ASX
NAB
National Australia Bank
ASX
ORG
Origin Energy
FX
AUDCAD
AUD vs CAD
COIN
BTCUSD
Bitcoin
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved